GLP-1 medications are known as subcutaneous injections, which means they must be injected under the skin and into the fatty layer just below the surface
"People taking these drugs for obesity often describe a quieting of 'food noise,' the persistent preoccupation with food that drives overeating," Al-Aly said
This approach ensures that patients with genuine deficiency receive rapid, effective treatment while those without deficiency are not subjected to unnecessary procedures
Ja, vooral in de vorm van Acetyl L-Carnitine , die gemakkelijk de bloed-hersenbarrire passeert
Quick Answer: GLP-1 agonists show preliminary promise for binge eating disorder but lack FDA approval and robust clinical trial evidence for this indication
Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, Lecker SH, Goldberg AL